PharmaShots | Incisive News in 3 Shots

Subscribe Now

Epilepsy

Disease of the Month: Epilepsy

Disease of the Month: Epilepsy

November 16, 2022

UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy

UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy

January 13, 2021

Neurocrine Signs a License Agreement with Xenon to Develop Therapies for Epilepsy

Neurocrine Signs a License Agreement with Xenon to Develop Therapies for Epilepsy

December 2, 2019

UCB's Nayzilam (midazolam) Receives FDA's Approval for the Treatment of Seizure Cluster in Epilepsy in the US

UCB's Nayzilam (midazolam) Receives FDA's Approval for the Treatment of Seizure Cluster in Epilepsy in the US

May 21, 2019

$NeuroPace Reports Positive Results of Next-Gen RNS System for Refractory Epilepsy in the US$

NeuroPace Reports Positive Results of Next-Gen RNS System for Refractory Epilepsy in the US

December 5, 2018

GW Pharmaceuticals' Epidiolex (cannabidiol) Receives FDA Approval for Epilepsy for 2yrs. or older

GW Pharmaceuticals' Epidiolex (cannabidiol) Receives FDA Approval for Epilepsy for 2yrs. or older

June 25, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us